{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:56Z","timestamp":1794047516051,"version":"4.8.0"},"reference-count":18,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"4","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2025.288418","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:08:54Z","timestamp":1761811734000},"page":"1449-1454","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell analysis unveils distinct transcriptional alterations and cellular origins in IgD multiple myeloma"],"prefix":"10.3324","volume":"111","author":[{"given":"Tianchen","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"88222","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023; 73(1):17-48.","DOI":"10.3322\/caac.21763"},{"key":"88223","doi-asserted-by":"crossref","unstructured":"Liu J, Lu J, Qiang W. Sensitive quantitative IgD assay increases progression-free survival prediction accuracy in IgD plasma cell myeloma. Leukemia. 2023; 37(2):497-499.","DOI":"10.1038\/s41375-022-01777-w"},{"key":"88224","doi-asserted-by":"crossref","unstructured":"Liu J, Hu X, Jia Y. Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN). Leukemia. 2021; 35(6):1797-1802.","DOI":"10.1038\/s41375-020-01060-w"},{"key":"88225","doi-asserted-by":"crossref","unstructured":"Lawless S, Sbianchi G, Morris C. IgD subtype but not IgM or non-secretory is a prognostic marker for poor survival following autologous hematopoietic cell transplantation in multiple myeloma. Results from the EBMT CALM (Collaboration to collect Autologous transplant outcomes in Lymphomas and Myeloma) study. Clin Lymphoma Myeloma Leuk. 2021; 21(10):686-693.","DOI":"10.1016\/j.clml.2021.05.012"},{"key":"88226","doi-asserted-by":"crossref","unstructured":"Schmidt TM, Fonseca R, Usmani SZ. Chromosome 1q21 abnormalities in multiple myeloma. Blood Cancer J. 2021; 11(4):83.","DOI":"10.1038\/s41408-021-00474-8"},{"key":"88227","doi-asserted-by":"crossref","unstructured":"Neupane K, Fortuna GG, Dahal R. Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood Cancer J. 2024; 14(1):20.","DOI":"10.1038\/s41408-024-00985-0"},{"key":"88228","doi-asserted-by":"crossref","unstructured":"Kang J, Brajanovski N, Chan KT, Xuan J, Pearson RB, Sanij E. Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy. Signal Transduct Target Ther. 2021; 6(1):323.","DOI":"10.1038\/s41392-021-00728-8"},{"key":"88229","doi-asserted-by":"crossref","unstructured":"Pih\u00e1n P, Carreras-Sureda A, Hetz C. BCL-2 family: integrating stress responses at the ER to control cell demise. Cell Death Diff. 2017; 24(9):1478-1487.","DOI":"10.1038\/cdd.2017.82"},{"key":"88230","doi-asserted-by":"crossref","unstructured":"Kumar SK, Harrison SJ. Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial. Lancet Oncol. 2020; 21(12):1630-1642.","DOI":"10.1016\/S1470-2045(20)30525-8"},{"key":"88231","doi-asserted-by":"crossref","unstructured":"Tirier SM, Mallm JP, Steiger S. Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics. Nat Commun. 2021; 12(1):6960.","DOI":"10.1038\/s41467-021-26951-z"},{"key":"88232","doi-asserted-by":"crossref","unstructured":"Herzog S, Reth M, Jumaa H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol. 2009; 9(3):195-205.","DOI":"10.1038\/nri2491"},{"key":"88233","doi-asserted-by":"crossref","unstructured":"Cancro MP. Signalling crosstalk in B cells: managing worth and need. Nat Rev Immunol. 2009; 9(9):657-661.","DOI":"10.1038\/nri2621"},{"key":"88234","doi-asserted-by":"crossref","unstructured":"Garraud O, Borhis G, Badr G. Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond. BMC Immunol. 2012; 13:63.","DOI":"10.1186\/1471-2172-13-63"},{"key":"88235","doi-asserted-by":"crossref","unstructured":"Andreani V, Ramamoorthy S, F\u00e4ssler R, Grosschedl R. Integrin \u03b21 regulates marginal zone B cell differentiation and PI3K signaling. J Exp Med. 2023; 220(1):e20220342.","DOI":"10.1084\/jem.20220342"},{"key":"88236","doi-asserted-by":"crossref","unstructured":"Pelletier J, Balzano M, Destin J. Niche-expressed galectin-1 is involved in pre-B acute lymphoblastic leukemia relapse through pre-B cell receptor activation. iScience. 2023; 26(4):106385.","DOI":"10.1016\/j.isci.2023.106385"},{"key":"88237","doi-asserted-by":"crossref","unstructured":"Touarin P, Serrano B, Courbois A. Pre-B cell receptor acts as a selectivity switch for galectin-1 at the pre-B cell surface. Cell Rep. 2024; 43(8):114541.","DOI":"10.1016\/j.celrep.2024.114541"},{"key":"88238","doi-asserted-by":"crossref","unstructured":"Gore Y, Starlets D, Maharshak N. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J Biol Chem. 2008; 283(5):2784-2792.","DOI":"10.1074\/jbc.M703265200"},{"key":"88239","doi-asserted-by":"crossref","unstructured":"Spagnuolo L, Puddinu V, Boss N. HMGB1 promotes CXCL12-dependent egress of murine B cells from Peyer\u2019s patches in homeostasis. Eur J Immunol. 2021; 51(8):1980-1991.","DOI":"10.1002\/eji.202049120"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/12965\/79024","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12965\/79884","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/12965\/79024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:10:08Z","timestamp":1794046208000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/12965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2025.288418","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,30]]}}}